|
MAGI3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95454763485259E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.82232007261973E-12 |
| Normal-vs-Stage2 |
1.68398628375144E-12 |
| Normal-vs-Stage3 |
1.36557432028894E-14 |
| Normal-vs-Stage4 |
6.64710000375379E-08 |
| Stage1-vs-Stage2 |
3.828000E-01 |
| Stage1-vs-Stage3 |
1.392960E-01 |
| Stage1-vs-Stage4 |
9.865000E-01 |
| Stage2-vs-Stage3 |
9.558000E-01 |
| Stage2-vs-Stage4 |
4.992200E-01 |
| Stage3-vs-Stage4 |
3.790000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76625380987616E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
2.60889998493496E-09 |
| Caucasian-vs-AfricanAmerican |
1.863440E-01 |
| Caucasian-vs-Asian |
9.374400E-01 |
| AfricanAmerican-vs-Asian |
5.944600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.71525074330748E-14 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.860800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.64046554118613E-12 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
1.75315317818558E-12 |
| Normal-vs-Extreme_Obese |
9.60760000445759E-08 |
| Normal_Weight-vs-Extreme_Weight |
7.380600E-01 |
| Normal_Weight-vs-Obese |
8.754600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.556200E-01 |
| Extreme_Weight-vs-Obese |
8.044000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.917200E-01 |
| Obese-vs-Extreme_Obese |
9.704800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31730190591861E-11 |
| Normal-vs-Age(41-60Yrs) |
3.15525383598469E-13 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.72761804861921E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.780200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.525600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.427900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.768780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.175900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.016800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.80866432941684E-12 |
| Normal-VS-Type2 PRCC |
1.63657976059994E-12 |
| Normal-VS-KIRP CIMP |
2.09979999998833E-06 |
| Normal-VS-Unclassified PRCC |
1.81488157835474E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.036400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.671010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.991000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.716300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.257600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.558800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92068583260152E-14 |
| Normal-vs-N1 |
5.68545210910543E-13 |
| Normal-vs-N2 |
5.412100E-04 |
| N0-vs-N1 |
9.448000E-02 |
| N0-vs-N2 |
3.327200E-01 |
| N1-vs-N2 |
9.431800E-01 |
|
|
